Growth Metrics

Guardian Pharmacy Services (GRDN) Cost of Revenue (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Cost of Revenue for 3 consecutive years, with $312.1 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 14.97% to $312.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 17.47% year-over-year, with the annual reading at $1.2 billion for FY2025, 17.47% up from the prior year.
  • Cost of Revenue hit $312.1 million in Q4 2025 for Guardian Pharmacy Services, up from $302.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $312.1 million in Q4 2025 to a low of $210.5 million in Q3 2023.
  • Historically, Cost of Revenue has averaged $257.7 million across 3 years, with a median of $259.2 million in 2024.
  • Biggest five-year swings in Cost of Revenue: grew 20.41% in 2024 and later increased 14.97% in 2025.
  • Year by year, Cost of Revenue stood at $226.5 million in 2023, then rose by 19.86% to $271.5 million in 2024, then increased by 14.97% to $312.1 million in 2025.
  • Business Quant data shows Cost of Revenue for GRDN at $312.1 million in Q4 2025, $302.7 million in Q3 2025, and $276.2 million in Q2 2025.